ABSTRACT OBJECTIVES This study sought to develop a validated, reproducible sterilization protocol, which could be used in the reprocessing of cardiac implantable electronic devices (CIEDs).
unavailable for many patients in low-and middle-income countries (LMICs), mainly because of the expense associated with this therapy, but also because of the underdevelopment of the health care infrastructure (5) .
It has been suggested that post-mortem collection and evaluation of CIEDs may be a means of improving access to brady-and tachy-therapies for patients, who are otherwise denied these lifesaving therapies (6, 7) .
However, device reuse remains controversial, and serious concerns about the safety of this practice remain (3, (8) (9) (10) . Increased risk of infection with a reused pacemaker or ICD is a major concern with CIED reuse.
Although pacemaker and ICD reconditioning has been described as a safe method for delivering electrophysiological health care, a blueprint for safe CIED reprocessing is lacking (7, 11, 12) . We have developed a protocol to clean and sterilize CIEDs, and present the protocol along with validation of the process. This represents one key step in our efforts to safely and effectively recycle used CIEDs.
METHODS
REPROCESSING. Receipt and inventory. As previously described, CIEDs were collected at funeral homes and crematories according to instructions available at http://www.med.umich.edu/myheartyourheart/ index.htm (13) . CIEDs with a dented housing or any broken parts were rejected and discarded. CIEDs that passed visual inspection were wiped with Lysol, sorted by manufacturer, interrogated for battery longevity, and logged into a CIED register. An overview of the product workflow is shown in Figure 1 . An abbreviated reprocessing protocol is presented here. Detailed description can be found in Online Appendix Section 1.
In order to develop methods to clean and sterilize devices, we selected an assortment of contemporary CIEDs, ranging from small pacemakers to large cardiac resynchronization therapy-defibrillators (CRT-Ds), representative of 3 manufacturers (Boston Scientific, Medtronic, and St. Jude Medical). Online Table 2 .1 lists the device types and models presented for reprocessing.
C l e a n i n g a n d d e c o n t a m i n a t i o n . CIEDs were placed side by side in a reverse osmosis/deionized (RO/DI) water sink and soaked for 10 minutes in Enzol enzymatic detergent solution (Advanced Sterilization
Products, Irvine, California).
B r i e f b a t t e r y r e t e s t . CIED outputs were connected to a 500-ohm test load. The devices were set to a predetermined test configuration: 1) mode: DDD (or VVI for single-chamber devices); 2) pacing output: 2.5 V at 1.0-ms pulse width; 3) pacing rate: 60 pulses per min; 4) any other sensors or device features turned off.
Battery condition was noted to determine if there was sufficient longevity based on pre-determined qualification criteria (4 years or >75% of the original battery life remaining). CIEDs were then configured to S c r e w c a p ( s e a l p l u g ) a n d s e t s c r e w r e m o v a l .
Using a sharp blade and a lighted magnifying glass, all screw covers were removed from the header. Set screws were removed from connector ports and inspected. Retained screw caps and set screws were rinsed in distilled water, wiped dry, sorted, and stored by manufacturer.
I n i t i a l c l e a n i n g . Forty CIEDs were placed side by side in an RO/DI sink and soaked for 3 minutes in Enzol solution. Set screws and seal plug were soaked in the enzymatic cleaner in a small container.
Wiping and brushing of devices. The CIEDs were wiped 4 times, including the header, with a lint-free towel. Any crevices on the housing and near the header were cleaned with a nylon brush. Pipe cleaner brushes were inserted into the connector ports in the header of the device, rotated 360 , and removed.
Each part of this step was repeated 4 times. The entire CIED was then gently cleaned with 6 strokes of a nylon brush while under the water's surface. Lead connector ports were inspected using a 5Â magnifier glass. If any debris was found, the entire wiping process was repeated. If debris still remained after 2 wiping and brushing cycles, the CIED was discarded.
The batch of 40 CIEDs was then pressure rinsed for 20
to 40 s with warm tap water.
E m e r s i o n s o a k r i n s i n g . Forty CIEDs were placed in the process basket and into an RO/DI sink with approximately 3 gallons of (RO/DI) water. After 3 minutes, the sink was drained. Immersion soak rinse was repeated 3 times. After the third rinse cycle, CIEDs were visually inspected for any damage. Any damaged devices were discarded. Set screws and seal plugs were handled in the same fashion.
D r y i n g . CIEDs, set screws, and seal plugs were placed in the vacuum drying chamber and dried in a vacuum at 35 C to 50 C for 7 h. S e t s c r e w r e a s s e m b l y a n d e l e c t r i c a l t e s t . All set screws and silicone set screw covers were visually Crawford et al.
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Crawford et al. were then subjected to half-cycle sterilization.
Three separate half-cycle tests and 3 separate fullcycle tests were performed (14) . Each BI was contained within the PCD. All validation runs were incubated for 7 days. 
Sterilization of Used CIEDs Cyt oto xicity/minimal ess ent ial medi um el utio n.
Ten reprocessed devices underwent cytotoxicity testing using the minimal essential medium elution method (17, 18) . Extractions were conducted at 37 C for 24 h using mammalian cell culture media (minimal essential medium with 5% serum). The extracts were plated on monolayer mouse fibroblast cells 
RESULTS
The results for bioburden, BI sterility testing, protein and hemoglobin residuals, total organic carbon, cytotoxicity, intracutaneous reactivity, pyrogenicity, and ethylene oxide and ethylene chlorohydrin residues are given in (19) .
Crawford et al. A common concern among physicians regarding CIED reuse is potential transmission of hepatitis C or 
